Statistics
Publications
6
Citations
2.8K
H-Index
6
Active since
2010
Daniel Rohle is an author at Memorial Sloan Kettering Cancer Center specializing in molecular oncology, oncology, and oncogenic signaling pathways.
Publications per year
2010–2022
6
6
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Şevin Turcan, Daniel Rohle, Anuj Goenka et al. · Nature · 2012 · 2K citations · Full text
Medicine, Cancer Biology, Oncology +14
Igor Vivanco, Daniel Rohle, Matthias Versele et al. · Proceedings of the National Academy of Sciences · 2010 · 105 citations · Full text
1–5 of 6